|
BAHD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.160100E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.660100E-02 |
| Normal-vs-Stage2 |
2.083200E-01 |
| Normal-vs-Stage3 |
3.789900E-02 |
| Normal-vs-Stage4 |
1.643460E-03 |
| Stage1-vs-Stage2 |
9.795800E-01 |
| Stage1-vs-Stage3 |
6.816200E-01 |
| Stage1-vs-Stage4 |
9.672000E-02 |
| Stage2-vs-Stage3 |
7.820000E-01 |
| Stage2-vs-Stage4 |
2.013200E-01 |
| Stage3-vs-Stage4 |
1.674620E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.198000E-02 |
| Normal-vs-AfricanAmerican |
6.786300E-04 |
| Normal-vs-Asian |
6.406100E-02 |
| Caucasian-vs-AfricanAmerican |
1.943050E-03 |
| Caucasian-vs-Asian |
8.443200E-01 |
| AfricanAmerican-vs-Asian |
1.181820E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.155610E-01 |
| Normal-vs-Female |
6.235700E-03 |
| Male-vs-Female |
3.002200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.992500E-02 |
| Normal-vs-Age(41-60Yrs) |
6.103900E-03 |
| Normal-vs-Age(61-80Yrs) |
9.761500E-02 |
| Normal-vs-Age(81-100Yrs) |
4.683400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.979000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.967000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.797800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.367200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.387200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.865600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.940800E-01 |
| Classical-VS-Follicular |
2.25099999999756E-05 |
| Classical-VS-Other |
8.997500E-02 |
| Classical-VS-Normal |
2.228500E-04 |
| Tall-VS-Follicular |
3.544000E-02 |
| Tall-VS-Other |
1.636160E-01 |
| Tall-VS-Normal |
6.249700E-02 |
| Follicular-VS-Other |
8.279200E-01 |
| Follicular-VS-Normal |
6.643000E-01 |
| Other-VS-Normal |
6.049400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.240610E-01 |
| Normal-vs-N1 |
4.991400E-01 |
| N0-vs-N1 |
6.289000E-01 |
|
|
